Skip to main content
MyCapitol LogoMyCapitol

HR 10150 · 119th Congress

Advancing Botanical Drug Development Act of 2026

This bill creates a new incentive to encourage pharmaceutical companies to develop drugs made from plants and natural botanical sources. Right now, companies that develop traditional synthetic drugs get 12 years of market exclusivity—meaning competitors can't make generic versions during that time. However, botanica…

Sponsor
Boebert, Lauren (R-Colorado)
Introduced
2026-08-27
Policy area
Health

Digging through Congress... 🔍